AU2011210227A1 - Process for the preparation of Temsirolimus and its intermediates - Google Patents

Process for the preparation of Temsirolimus and its intermediates Download PDF

Info

Publication number
AU2011210227A1
AU2011210227A1 AU2011210227A AU2011210227A AU2011210227A1 AU 2011210227 A1 AU2011210227 A1 AU 2011210227A1 AU 2011210227 A AU2011210227 A AU 2011210227A AU 2011210227 A AU2011210227 A AU 2011210227A AU 2011210227 A1 AU2011210227 A1 AU 2011210227A1
Authority
AU
Australia
Prior art keywords
formula
compound
rapamycin
temsirolimus
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011210227A
Other languages
English (en)
Inventor
Sushil Kumar Dubey
Nitin Gupta
Vishal Handa
Saswata Lahiri
Abir Kumar Pal
Hemat Kumar Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Oncology Ltd
Original Assignee
Fresenius Kabi Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Oncology Ltd filed Critical Fresenius Kabi Oncology Ltd
Publication of AU2011210227A1 publication Critical patent/AU2011210227A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2011210227A 2010-01-28 2011-01-20 Process for the preparation of Temsirolimus and its intermediates Abandoned AU2011210227A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN173/DEL/2010 2010-01-28
IN173DE2010 2010-01-28
PCT/IB2011/000084 WO2011092564A2 (en) 2010-01-28 2011-01-20 Process for the preparation of temsirolimus and its intermediates

Publications (1)

Publication Number Publication Date
AU2011210227A1 true AU2011210227A1 (en) 2012-08-30

Family

ID=44022850

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011210227A Abandoned AU2011210227A1 (en) 2010-01-28 2011-01-20 Process for the preparation of Temsirolimus and its intermediates

Country Status (5)

Country Link
US (1) US8524893B2 (https=)
EP (1) EP2528906A2 (https=)
JP (1) JP2013518093A (https=)
AU (1) AU2011210227A1 (https=)
WO (1) WO2011092564A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102020662B (zh) * 2011-01-07 2013-02-13 天津市炜杰科技有限公司 一种驮瑞塞尔制备方法
CN102807571A (zh) * 2012-05-25 2012-12-05 上海现代制药股份有限公司 一种适于工业化生产坦西莫司的制备方法
CN108948047A (zh) * 2017-05-20 2018-12-07 鲁南制药集团股份有限公司 一种替西罗莫司的纯化方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
SE510128C2 (sv) * 1997-06-26 1999-04-19 Perstorp Ab Förfarande för framställning av dendritisk polyol
TWI256395B (en) * 1999-09-29 2006-06-11 Wyeth Corp Regioselective synthesis of rapamycin derivatives
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
US7097856B2 (en) * 2000-09-29 2006-08-29 The Regents Of The University Of California Dendrimeric support or carrier macromolecule
KR20060057605A (ko) * 2003-08-07 2006-05-26 와이어쓰 Ｃｃｉ-779의 위치선택적 합성 방법
TW201035104A (en) 2009-03-27 2010-10-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Improved synthesis method for Temsirolimus and its similar compounds

Also Published As

Publication number Publication date
US8524893B2 (en) 2013-09-03
EP2528906A2 (en) 2012-12-05
WO2011092564A4 (en) 2012-01-19
JP2013518093A (ja) 2013-05-20
US20110184167A1 (en) 2011-07-28
WO2011092564A3 (en) 2011-12-01
WO2011092564A2 (en) 2011-08-04
WO2011092564A8 (en) 2012-09-13

Similar Documents

Publication Publication Date Title
ES2287772T3 (es) Sintesis regioselectiva de cci-779.
US5221670A (en) Rapamycin esters
AU653175B2 (en) Carboxylic acid esters of rapamycin
AU672006B2 (en) Taxol derivatives
US5861515A (en) Process for the preparation of taxane derivatives
SK43595A3 (en) Method of preparing taxane derivatives
CA2068567A1 (en) Amide esters of rapamycin
US5358944A (en) Rapamycin esters for treating transplantation rejection
IE921022A1 (en) Silyl ethers of rapamycin
EP2933250B1 (en) Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof
HU217115B (hu) Eljárás taxánszármazékok előállítására
WO1998009972A1 (en) Rapamycin derivatives with unnatural stereochemistries
US20080097093A1 (en) Processes for the synthesis of individual isomers of mono-peg CCI-779
US5739359A (en) Methods for preparing 1-deoxy paclitaxels
CA2615581A1 (en) Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
Clark et al. Studies towards the synthesis of esperamicinone
CN1235608A (zh) 烷基化的雷帕霉素衍生物
AU2011210227A1 (en) Process for the preparation of Temsirolimus and its intermediates
EP0712854B1 (en) Baccatin derivatives and processes for preparing the same
JP2009512662A (ja) 中間体、並びにかかる中間体を用いたエクチナサイジン５８３、５９７などのエクチナサイジン類の調製方法
WO1993018043A1 (en) Novel rapamycin 42-sulfonates and 42-(n-carboalkoxy)sulfamates useful as immunosuppressive agents
JP5492786B2 (ja) ゼラレノンマクロライドアナログを作製するための中間体および方法
WO2008054233A2 (en) Process for the preparation of docetaxel
JP4690039B2 (ja) １４位で官能化されたタキサン誘導体及びその製造方法
JPH11140071A (ja) バッカチン誘導体及びその製法

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application